Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 16, Issue 6, pp. 1246-1252
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted April 11, 2007
- Received January 9, 2007
- Revision received March 12, 2007
- Published first June 4, 2007.
Copyright & Usage
American Association for Cancer Research
Author Information
- David J. Boocock1,
- Guy E.S. Faust1,
- Ketan R. Patel1,
- Anna M. Schinas2,
- Victoria A. Brown1,
- Murray P. Ducharme2,
- Tristan D. Booth3,
- James A. Crowell4,
- Marjorie Perloff4,
- Andreas J. Gescher1,
- William P. Steward1 and
- Dean E. Brenner5
- 1Cancer Biomarkers and Prevention Group, Department of Cancer Studies and Molecular Medicine, Leicester University, Leicester, United Kingdom; 2MDS Pharma Services; 3Royalmount Pharma, Montreal, Canada; 4Chemopreventive Agent Development Research Group, National Cancer Institute, Bethesda, Maryland; and 5Departments of Internal Medicine and Pharmacology, University of Michigan Medical School and VA Medical Center, Ann Arbor, Michigan
- Requests for reprints:
Andreas J. Gescher, Department of Cancer Studies and Molecular Medicine, Leicester Royal Infirmary, Robert Kilpatrick Clinical Sciences Building, Leicester University, Leicester LE2 7LX, United Kingdom; Phone: 44-116-223-1856; Fax: 44-116-223-1855. E-mail: ag15{at}le.ac.uk
June 2007
Volume 16, Issue 6
Volume 16, Issue 6
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent
Jump to section
Advertisement